Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease
Clinical trial NCT04639050 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04639050
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2027-07-31
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.